156 related articles for article (PubMed ID: 4085353)
1. The effects of activated charcoal on digoxin and digitoxin clearance.
Park GD; Goldberg MJ; Spector R; Johnson GF; Feldman RD; Quee CK; Roberts P
Drug Intell Clin Pharm; 1985 Dec; 19(12):937-41. PubMed ID: 4085353
[TBL] [Abstract][Full Text] [Related]
2. Digoxin and digitoxin elimination in man by charcoal hemoperfusion.
Gilfrich HJ; Okonek S; Manns M; Schuster CJ
Klin Wochenschr; 1978 Dec; 56(23):1179-83. PubMed ID: 713438
[TBL] [Abstract][Full Text] [Related]
3. Effect of administration of activated charcoal and fibre on absorption, excretion and steady state blood levels of digoxin and digitoxin. Evidence for intestinal secretion of the glycosides.
Reissell P; Manninen V
Acta Med Scand Suppl; 1982; 668():88-90. PubMed ID: 6963097
[TBL] [Abstract][Full Text] [Related]
4. Acceleration of digoxin clearance by activated charcoal.
Lalonde RL; Deshpande R; Hamilton PP; McLean WM; Greenway DC
Clin Pharmacol Ther; 1985 Apr; 37(4):367-71. PubMed ID: 3978996
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of the experimental chronic digitalisintoxication by hemoperfusion (author's transl)].
Bischoff KO; Flohr E; Graben N; Hager W; Merguet P
Z Kardiol; 1977 Nov; 66(11):656-62. PubMed ID: 595775
[TBL] [Abstract][Full Text] [Related]
6. Effect of ketanserin on the kinetics of digoxin and digitoxin.
Ochs HR; Verburg-Ochs B; Höller M; Greenblatt DJ
J Cardiovasc Pharmacol; 1985; 7(1):205-7. PubMed ID: 2580144
[TBL] [Abstract][Full Text] [Related]
7. Digitalis therapy in renal failure with special regard to digitoxin.
Vöhringer HF; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):175-84. PubMed ID: 7021432
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of digoxin and digitoxin in patients undergoing hemodialysis.
Finkelstein FO; Goffinet JA; Hendler ED; Lindenbaum J
Am J Med; 1975 Apr; 58(4):525-31. PubMed ID: 1124790
[TBL] [Abstract][Full Text] [Related]
9. Digoxin toxicity in chronic renal failure: treatment by multiple dose activated charcoal intestinal dialysis.
Critchley JA; Critchley LA
Hum Exp Toxicol; 1997 Dec; 16(12):733-5. PubMed ID: 9429088
[TBL] [Abstract][Full Text] [Related]
10. Interindividual differences in the pharmacokinetics of digitoxin and digoxin during long-term treatment.
Haustein KO
Eur J Clin Pharmacol; 1981 Jan; 19(1):45-51. PubMed ID: 7461023
[TBL] [Abstract][Full Text] [Related]
11. Digitalis pharmacokinetics and metabolism.
Marcus FI
Am J Med; 1975 Apr; 58(4):452-9. PubMed ID: 1092160
[TBL] [Abstract][Full Text] [Related]
12. Digitalis pharmacokinetics and therapy with respect to impaired renal function.
Kramer P
Klin Wochenschr; 1977 Jan; 55(1):1-11. PubMed ID: 319291
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic aspects of digoxin in patients with terminal renal failure. IV. Clinical implications of own observations with a recent review of literature.
van der Vijgh WJ; Oe PL
Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):540-6. PubMed ID: 730421
[TBL] [Abstract][Full Text] [Related]
14. Current status of cardiac glycoside drug interactions.
Hooymans PM; Merkus FW
Clin Pharm; 1985; 4(4):404-13. PubMed ID: 2412751
[TBL] [Abstract][Full Text] [Related]
15. Management of yellow oleander poisoning.
Rajapakse S
Clin Toxicol (Phila); 2009 Mar; 47(3):206-12. PubMed ID: 19306191
[TBL] [Abstract][Full Text] [Related]
16. Activated charcoal increases digoxin elimination in patients.
Ibañez C; Carcas AJ; Frias J; Abad F
Int J Cardiol; 1995 Jan; 48(1):27-30. PubMed ID: 7744534
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of digoxin absorption but not of digitoxin during cytostatic drug therapy.
Kuhlmann J
Arzneimittelforschung; 1982; 32(6):698-704. PubMed ID: 6889430
[TBL] [Abstract][Full Text] [Related]
18. Reduction of digitalis glycoside intoxication by rational dosing procedures.
Clayton BD
Am J Hosp Pharm; 1974 Sep; 31(9):855-65. PubMed ID: 4418578
[No Abstract] [Full Text] [Related]
19. Pharmacokinetics of tritiated ouabain, digoxin and digitoxin in guinea-pigs.
Proppe D
Clin Exp Pharmacol Physiol; 1975; 2(6):489-502. PubMed ID: 1236603
[TBL] [Abstract][Full Text] [Related]
20. Differences in color vision impairment caused by digoxin, digitoxin, or pengitoxin.
Haustein KO; Oltmanns G; Rietbrock N; Alken RG
J Cardiovasc Pharmacol; 1982; 4(4):536-41. PubMed ID: 6181326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
